Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
NYSE Content Advisory: Pre-Market Update + S&P 500 closes above 6,600 for first time
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- The New York Stock Exchange…
The Upcoming 8th CIIE: Countdown to Global Opportunities and Collaboration
SHANGHAI, Sept. 16, 2025 /PRNewswire/ --Â With the 8th China International Import Expo…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…
DERMALOG Wins Prestigious International Competition for Iris Recognition Security
Biometrics leader DERMALOG outperforms global competitors in LivDet-Iris 2025, achieving 99.99 percent…
Vantage Shines as Titanium Sponsor at Money Expo Chile 2025
PORT VILA, Vanuatu, Sept. 16, 2025 /PRNewswire/ -- Vantage Markets proudly participated…
LCM Partners Announces 3.8 Billion First Close of Credit Opportunities 5 Strategy
LONDON, Sept. 16, 2025 /PRNewswire/ -- LCM Partners, one of Europe's leading…
Clinically Proven Human Milk Probiotic LC40 supports Infant Health and Breastfeeding Mothers
SINGAPORE, Sept. 15, 2025 /PRNewswire/ --Â Supported by six clinical studies and two…
THE HOUSE OF LAKM WELCOMES ANEET PADDA AS A NEW FACE OF THE BRAND, TO REDEFINE BEAUTY FOR GEN Z
The Freshest Face of Bollywood reflects LakmÄ“'s vision of effortless, expressive beauty,…
Medit Link Express for iPad Debuts as Medit i900 Mobility Goes into Shipping
SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Medit (www.medit.com), a global…